The PE Ratio as of December 2024 (TTM) for Amphastar Pharmaceuticals, Inc. (AMPH) is 12.68

According to Amphastar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 12.68. This represents a change of -14.94% compared to the average of 14.91 of the last 4 quarters.

Amphastar Pharmaceuticals, Inc. (AMPH) Historical PE Ratio (quarterly & annually)

How has AMPH PE Ratio performed in the past?

The mean historical PE Ratio of Amphastar Pharmaceuticals, Inc. over the last ten years is 77.55. The current 12.68 PE Ratio has changed 1.54% with respect to the historical average. Over the past ten years (40 quarters), AMPH's PE Ratio was at its highest in in the September 2017 quarter at 1.18K. The PE Ratio was at its lowest in in the June 2020 quarter at -1367.28.

Amphastar Pharmaceuticals, Inc. (AMPH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amphastar Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amphastar Pharmaceuticals, Inc. (AMPH) Average PE Ratio

How has AMPH PE Ratio performed in the past?

The current PE Ratio of Amphastar Pharmaceuticals, Inc. (AMPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Amphastar Pharmaceuticals, Inc. (AMPH) PE Ratio vs. Peers

How is AMPH’s PE Ratio compared to its peers?

Amphastar Pharmaceuticals, Inc.’s PE Ratio is greater than Collegium Pharmaceutical, Inc. (10.61), greater than Eagle Pharmaceuticals, Inc. (0.19), less than Alkermes plc (14.46), greater than Evolus, Inc. (-12.23), less than Neurocrine Biosciences, Inc. (35.91), less than Ironwood Pharmaceuticals, Inc. (29.73), greater than ANI Pharmaceuticals, Inc. (-147.47), less than Prestige Consumer Healthcare Inc. (18.97), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Pacira BioSciences, Inc. (-9.81), less than Phibro Animal Health Corporation (50.12), greater than Evotec SE (-8.70), less than Supernus Pharmaceuticals, Inc. (32.73),

Build a custom stock screener for Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amphastar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amphastar Pharmaceuticals, Inc. (AMPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amphastar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.